Sex differences in the genetic architecture of susceptibility to Cryptococcus neoformans pulmonary infection

被引:0
|
作者
S F Carroll
J C Loredo Osti
L Guillot
K Morgan
S T Qureshi
机构
[1] Centre for the Study of Host Resistance,Department of Human Genetics
[2] McGill University,Department of Mathematics and Statistics
[3] McGill University,Department of Medicine
[4] Memorial University,undefined
[5] Montreal General Hospital,undefined
[6] McGill University,undefined
来源
Genes & Immunity | 2008年 / 9卷
关键词
mouse model; complex trait; QTL;
D O I
暂无
中图分类号
学科分类号
摘要
Cryptococcus neoformans is a major cause of fungal pneumonia, meningitis and disseminated disease in the immune compromised host. Here we have used a clinically relevant model to investigate the genetic determinants of susceptibility to progressive cryptococcal pneumonia in C57BL/6J and CBA/J inbred mice. At 5 weeks after infection, the lung fungal burden was over 1000-fold higher in C57BL/6J compared to CBA/J mice. A genome-wide scan performed on 210 male and 203 female (CBA/J × C57BL/6J) F2 progeny using lung colony-forming units as a quantitative trait revealed a sex difference in genetic architecture with three loci (designated Cnes1–Cnes3) associated with susceptibility to cryptococcal pneumonia. Single locus analysis identified significant loci on chromosomes 3 (Cnes1) and 17 (Cnes2) with logarithm of the odds (LOD) scores of 4.09 (P=0.0110) and 7.30 (P<0.0001) that explained 8.9 and 15.9% of the phenotypic variance, respectively, in female CBAB6F2 and one significant locus on chromosome 17 (Cnes3) with a LOD score of 4.04 (P=0.010) that explained 8.6% of the phenotypic variance in male CBAB6F2 mice. Genome-wide pair-wise analysis revealed significant quantitative trait locus interactions in both the female and male CBAB6F2 progeny that collectively explained 43.8 and 19.5% of phenotypic variance in each sex, respectively.
引用
收藏
页码:536 / 545
页数:9
相关论文
共 50 条
  • [21] Susceptibility to Cryptococcus neoformans Infection with Bruton's Tyrosine Kinase Inhibition
    Messina, Julia A.
    Giamberardino, Charles D.
    Tenor, Jennifer L.
    Toffaletti, Dena L.
    Schell, Wiley A.
    Asfaw, Yohannes G.
    Palmucci, Julia R.
    Lionakis, Michail S.
    Perfect, John R.
    INFECTION AND IMMUNITY, 2023, 91 (08)
  • [23] Cryptococcus neoformans infection in malignancy
    Schmalzle, Sarah A.
    Buchwald, Ulrike K.
    Gilliam, Bruce L.
    Riedel, David J.
    MYCOSES, 2016, 59 (09) : 542 - 552
  • [24] CRYPTOCOCCUS NEOFORMANS INFECTION IN A DOG
    WAGNER, JL
    PICK, JR
    KRIGMAN, MR
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1968, 153 (07) : 945 - &
  • [25] Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection
    Feldmesser, M
    Kress, Y
    Casadevall, A
    MICROBIOLOGY-SGM, 2001, 147 : 2355 - 2365
  • [26] Scavenger Receptor A Modulates the Immune Response to Pulmonary Cryptococcus neoformans Infection
    Qiu, Yafeng
    Dayrit, Jeremy K.
    Davis, Michael J.
    Carolan, Jacob F.
    Osterholzer, John J.
    Curtis, Jeffrey L.
    Olszewski, Michal A.
    JOURNAL OF IMMUNOLOGY, 2013, 191 (01): : 238 - 248
  • [27] Molecular architecture of the Cryptococcus neoformans capsule
    Gates, MA
    Thorkildson, P
    Kozel, TR
    MOLECULAR MICROBIOLOGY, 2004, 52 (01) : 13 - 24
  • [28] Diversity of the T-cell response to pulmonary Cryptococcus neoformans infection
    Lindell, Dennis M.
    Ballinger, Megan N.
    McDonald, Roderick A.
    Toews, Galen B.
    Huffnagle, Gary B.
    INFECTION AND IMMUNITY, 2006, 74 (08) : 4538 - 4548
  • [29] Metabolic adaptation in Cryptococcus neoformans during early murine pulmonary infection
    Hu, Guanggan
    Cheng, Po-Yan
    Sham, Anita
    Perfect, John R.
    Kronstad, James W.
    MOLECULAR MICROBIOLOGY, 2008, 69 (06) : 1456 - 1475
  • [30] Role of cytokines in T cell immunity to a pulmonary Cryptococcus neoformans infection
    Huffnagle, GB
    BIOLOGICAL SIGNALS, 1996, 5 (04): : 215 - 222